Michal A Miller

Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma.

T. Griffith, A. Sandler, T. Azuhata, 2006, Journal of pediatric surgery.

CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.

A. Krieg, A. Sandler, Xiaoyan Zhu, 2003, Cancer research.

Prognostic Value of Quantifying Apoptosis Factor Expression in Favorable Histology Wilms Tumors

N. Breslow, P. Grundy, M. O'dorisio, 2005, Journal of pediatric hematology/oncology.

Elevated plasma vascular endothelial growth factor levels in 2 patients with hemangioendothelioma.

A. Sandler, Michal A Miller, 2005, Journal of pediatric surgery.

Clinical Examination for Outcome Prediction in Nontraumatic Coma

Michal A Miller, 2012 .

Survivin mRNA Levels Are Associated With Biology of Disease and Patient Survival in Neuroblastoma: A Report From the Children's Oncology Group

W. London, M. Hogarty, A. Sandler, 2006, Journal of pediatric hematology/oncology.